Literature DB >> 18498424

Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis.

Asher Winder, Rafi Lefkowitz, Hussam Ghoti, Merav Leiba, Tomas Ganz, Elizabeta Nemeth, Eliezer A Rachmilewitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18498424     DOI： 10.1111/j.1365-2141.2008.07225.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  The treatment of secondary hemochromatosis.

Authors:  Norbert Gattermann
Journal:  Dtsch Arztebl Int       Date:  2009-07-24       Impact factor: 5.594

Review 2.  Hepcidin modulation in human diseases: from research to clinic.

Authors:  Alberto Piperno; Raffaella Mariani; Paola Trombini; Domenico Girelli
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

3.  Hepcidin levels and their determinants in different types of myelodysplastic syndromes.

Authors:  Valeria Santini; Domenico Girelli; Alessandro Sanna; Nicola Martinelli; Lorena Duca; Natascia Campostrini; Agostino Cortelezzi; Michela Corbella; Alberto Bosi; Gianluigi Reda; Oliviero Olivieri; Maria Domenica Cappellini
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

4.  New insights on iron study in myelodysplasia.

Authors:  Noha M El Husseiny; Dina Ahmed Mehaney; Mohamed Abd El Kader Morad
Journal:  Turk J Haematol       Date:  2014-12-05       Impact factor: 1.831

Review 5.  Myelodysplasia is in the niche: novel concepts and emerging therapies.

Authors:  E Bulycheva; M Rauner; H Medyouf; I Theurl; M Bornhäuser; L C Hofbauer; U Platzbecker
Journal:  Leukemia       Date:  2014-11-14       Impact factor: 11.528

6.  The role of hepcidin, GDF15, and mitoferrin-1 in iron metabolism of polycythemia vera and essential thrombocytosis patients

Authors:  Canan Albayrak; Pınar Tarkun; Elif Birtaş Ateşoğlu; Ceyla Eraldemir; Özgür Doğa Özsoy; Esra Terzi Demirsoy; Özgür Mehtap; Alper Gedük; Abdullah Hacıhanefioğlu
Journal:  Turk J Med Sci       Date:  2019-02-11       Impact factor: 0.973

Review 7.  The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia.

Authors:  Sarah Weber; Anastasia Parmon; Nina Kurrle; Frank Schnütgen; Hubert Serve
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.